Results 191 to 200 of about 1,169,724 (211)
Erythropoietin administration suppresses hepatic soluble epoxide hydrolase (sEH) expression, leading to increased CYP‐derived epoxides. This is associated with a shift in hepatic macrophage polarization characterized by reduced M1 markers and increased M2 markers, along with reduced hepatic inflammation, suppressed hepatic lipogenesis, and attenuated ...
Takeshi Goda +12 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Treatment of renal cell carcinoma: Current status and future directions
Ca-A Cancer Journal for Clinicians, 2017Pedro Coelho Barata, Brian I Rini
exaly
Evolving standards of care and new challenges in the management of HER2‐positive breast cancer
Ca-A Cancer Journal for Clinicians, 2020Grace M Choong +2 more
exaly
The unfolded protein response: controlling cell fate decisions under ER stress and beyond
Nature Reviews Molecular Cell Biology, 2012Claudio Hetz
exaly
Angiogenesis Inhibitors: Current Strategies and Future Prospects
Ca-A Cancer Journal for Clinicians, 2010Kristina M Cook, William D Figg
exaly
Recent progress in the treatment and prevention of cancer‐related lymphedema
Ca-A Cancer Journal for Clinicians, 2015Simona F Shaitelman +2 more
exaly
Chemotherapy-Related Nausea and Vomiting: Etiology and Management
Ca-A Cancer Journal for Clinicians, 1989Gary R Morrow
exaly

